EUVIMEDEUVIMED entdecken
Crossref

Lipase mediated new chemo‐enzymatic synthesis of ( RS )‐, ( R )‐, and ( S )‐bunolol

Ravinder Reddy Patlolla, Pulivarthi Deepthi, Gajjala Raveena, Khawlhring Rosangzuala, Somarowthu Tejaswini, Reddy Shetty Prakasham, Linga Banoth iD

Chirality · 2024-01 · 36 (1)

DOI: 10.1002/chir.23627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chirality, online erschienen am 13.11.2023. Verfasst von Ravinder Reddy Patlolla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India. Hauptthemen laut MEDLINE: Lipase, Bunolol. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: DST-SERB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β‐adrenergic receptor blocking agents are an important class of drug molecules. The present study reports a new chemo and chemo‐enzymatic synthetic process for ( RS )‐, ( R )‐, and ( S )‐bunolol, one of the potent β‐adrenergic receptor blocker. In chemo‐enzymatic process, CAL L4777 lipase was employed for enantioselective kinetic resolution to synthesize the enantiopure ( R )‐alcohol and ( S )‐ester from the corresponding racemic alcohol. Thereafter, the corresponding ( R )‐alcohol and deacylated ( S )‐ester were treated with tert ‐butylamine to produce ( S )‐ and ( R )‐bunolol, respectively. In chemical approach, epichlorohydrin ( RS ‐, R‐ , and S ‐) was used as a starting material via respective ( RS )‐, ( S )‐, and ( R )‐glycidyl ether as intermediates for synthesis of enantiomeric ( RS )‐, ( R )‐, and ( S )‐bunolol. In comparison between two approaches, it was found that the chemo‐enzymatic process was more effective and resulted in enantiomeric excess of 98% with 35% yield.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipaseBunololStereoisomerismAdrenergic beta-AntagonistsEstersReceptors, Adrenergic, beta

Stichwörter der Autor:innen

biocatalysischemo-enzymatic synthesislevobunolollipase

Substanzen

LipaseBunololAdrenergic beta-AntagonistsEstersReceptors, Adrenergic, beta

Autor:innen und Institutionen

  • Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Fluoro Agrochemicals, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.

ORCID-Profile: Linga Banoth

Förderung

  • DST-SERB

Zitieren

APA

Patlolla, R. R., Deepthi, P., Raveena, G., Rosangzuala, K., Tejaswini, S., Prakasham, R. S., & Banoth, L. (2024). Lipase mediated new chemo‐enzymatic synthesis of ( RS )‐, ( R )‐, and ( S )‐bunolol. Chirality, 36(1). https://doi.org/10.1002/chir.23627

Vancouver

Patlolla RR, Deepthi P, Raveena G, Rosangzuala K, Tejaswini S, Prakasham RS, et al. Lipase mediated new chemo‐enzymatic synthesis of ( RS )‐, ( R )‐, and ( S )‐bunolol. Chirality. 2024;36(1). doi:10.1002/chir.23627

BibTeX
@article{Patlolla2024,
  author = {Patlolla, Ravinder Reddy and Deepthi, Pulivarthi and Raveena, Gajjala and Rosangzuala, Khawlhring and Tejaswini, Somarowthu and Prakasham, Reddy Shetty and Banoth, Linga},
  title = {Lipase mediated new chemo‐enzymatic synthesis of ( RS )‐, ( R )‐, and ( S )‐bunolol},
  journal = {Chirality},
  year = {2024},
  volume = {36},
  number = {1},
  doi = {10.1002/chir.23627}
}
Kostenlos starten →